FIELD: medicine.
SUBSTANCE: invention relates to immunology, virology, biotechnology and laboratory diagnostics in medicine. Method for determining production of interferons as congenital immunity parameters, characterized by the use of a mammalian cell culture sensitive to IFN infected with VSV, differs in using a culture of green monkey (Vero) kidney tubule epithelial cells as a mammalian cell culture, quantifying the production of interferons of type I and II, based on an estimate of 50 % protection of a monolayer of serum-free line of green monkey (Vero) kidney tubule epithelial cells from cytodestructive effect induced by vesicular stomatitis test-virus (VSV); method comprises introducing individual samples into wells with an IFN-sensitive cell culture of Vero and subsequent treatment with a VSV test virus.
EFFECT: invention can be used to diagnose congenital immunity parameters and in various infectious diseases (viral, bacterial, fungal) and non-infectious (allergic, autoimmune, oncological) etiology.
8 cl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR NEUTRALISING ANTIBODIES DETERMINATION IN BLOOD SERUM OF PATIENTS WITH MULTIPLE SCLEROSIS, TREATED WITH INTERFERON-BETA DRUGS | 2016 |
|
RU2626832C1 |
TEST SYSTEM FOR HUMAN INTERFERON ACTIVITY TESTING | 2013 |
|
RU2553431C2 |
METHOD OF DETERMINING INDIVIDUAL HUMAN BLOOD LEUKOCYTE DRUG SENSITIVITY | 2009 |
|
RU2423705C2 |
METHOD OF DETERMINING BIOLOGICAL ACTIVITY OF MEASLES, EPIDEMIC PAROTITIS AND RUBELLA DURING PRODUCTION OF ASSOCIATED PREPARATIONS (VERSIONS) | 2015 |
|
RU2606848C2 |
INDOLE-3-CARBOXYLIC ACID DERIVATIVE HAVING ANTIVIRAL ACTIVITY ON SARS-CoV-2 | 2022 |
|
RU2820633C1 |
AGENT FOR VIRUS DISEASES PREVENTION AND TREATMENT AND METHOD OF VIRUS DISEASES PREVENTION AND TREATMENT | 2007 |
|
RU2337703C1 |
INTERFERON INDUCING AGENT | 1998 |
|
RU2132681C1 |
MELANINE ANTIVIRAL AGENT | 2011 |
|
RU2480227C2 |
METHOD OF PRODUCING ANTIGEN OF ZIKA VIRUS, HAVING IMMUNOGENIC AND ANTIGENIC PROPERTIES | 2019 |
|
RU2717993C1 |
ALPHA-INTERFERON COMPOSITION AND METHOD OF PREPARATION THEREOF FROM HUMAN BLOOD LEUKOCYTES | 1993 |
|
RU2129437C1 |
Authors
Dates
2018-06-15—Published
2017-07-10—Filed